Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
But obesity therapeutics are moving very quickly, and clinicians increasingly need practical tools to translate changing trial evidence into everyday decision-making. Beyond Drug Choice: Nutrition, Function, and Psychology Obesity and dietitian societies also issued a new consensus statement at ECO 2026, calling for incretin-based obesity therapies such as GLP-1 receptor agonists to be integrated with dietetic, psychological, and functional support rather than used as stand-alone treatments
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
These are from Dr
If you are considering treatment and want to check eligibility, you can start with the free assessment quiz
Bousema, T., Okell, L., Felger, I
US$ 23.05
US$ 20.29
US$ 28.49
US$ 23.65
US$ 28.67
US$ 23.86
US$ 27.78
